Morgan Stanley
DSCI

Morgan Stanley’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Morgan Stanley’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,257
Closed -$64K – 6786
2016
Q4 		$64K Sell
12,257
-1,451
-11% -$6.82K ﹤0.01% 5690
2016
Q3 		$64K Buy
13,708
+11,665
+571% +$54.4K ﹤0.01% 5493
2016
Q2 		$8K Sell
2,043
-5,309
-72% -$19.8K ﹤0.01% 6132
2016
Q1 		$23K Sell
7,352
-4,485
-38% -$15K ﹤0.01% 5885
2015
Q4 		$55K Sell
11,837
-5,812
-33% -$27.6K ﹤0.01% 5678
2015
Q3 		$83K Sell
17,649
-4,841
-22% -$31.3K ﹤0.01% 5503
2015
Q2 		$161K Buy
22,490
+11,865
+112% +$89.2K ﹤0.01% 5352
2015
Q1 		$90K Buy
10,625
+455
+4% +$3.88K ﹤0.01% 5576
2014
Q4 		$94K Sell
10,170
-7,277
-42% -$63.3K ﹤0.01% 5577
2014
Q3 		$146K Buy
17,447
+4,570
+35% +$42.3K ﹤0.01% 5304
2014
Q2 		$148K Buy
12,877
+3,436
+36% +$35.3K ﹤0.01% 5312
2014
Q1 		$120K Buy
9,441
+8,192
+656% +$106K ﹤0.01% 5375
2013
Q4 		$14K Buy
+1,249
New +$14.5K ﹤0.01% 5976

Other funds holding DSCI

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Morgan Stanley's DSCI Position: Q1 2017 in Review

Morgan Stanley sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 12,257 shares — an estimated $64K sold.

Morgan Stanley first reported a position in DSCI in Q4 2013 and held it in 13 quarters. The position peaked at $161K in Q2 2015. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

  • Morgan Stanley reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
  • Morgan Stanley sold 12,257 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $64K.
  • Morgan Stanley first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q4 2013 and held it in 13 quarters.
  • Morgan Stanley's Derma Sciences, Inc. Common Stock (DE) position peaked at $161K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on Morgan Stanley's 13F filing for Q1 2017, filed 12 May 2017.